Altera Biosciences
July 2025 · South AfricaActivity : Pharmaceutical manufacturing
Altera Biosciences Bags $1.6M to Build ‘Off-the-Shelf’ Cells in Africa’s First Gene Therapy Play.
Co-investors E Squared
Source : launchbaseafrica.com
Investisseur référencé à partir d'opérations publiées. Secteurs, pays, instruments et tickets affichés d'après ses opérations ; le fonds peut revendiquer sa fiche pour préciser sa thèse.
Based on observed investment behaviour: 1 recorded deal
Fewer than three recorded deals: insufficient evidence to compare thesis and behaviour.
Does this fund fit your project?
Describe your need: the target list shows, for each source of capital, why it fits and which deals prove it.
Criteria inferred from recorded deals: the fund has not stated its thesis yet.
* added from its deals
Recent public deals: they say better than a thesis what the fund actually signs.
Activity : Pharmaceutical manufacturing
Altera Biosciences Bags $1.6M to Build ‘Off-the-Shelf’ Cells in Africa’s First Gene Therapy Play.
Co-investors E Squared
Source : launchbaseafrica.com
OneBio invests tickets ranging from 1.6 M$ to 1.6 M$, across the following sectors: Healthcare, in the following areas: South Africa. Check in 30 seconds whether your company fits these criteria.